We were delighted to talk to Dr Stella Lee (University of Pittsburgh, Pittsburgh, PA, US) around the current and future treatment options for chronic rhinosinusitis with nasal polyps.
Questions
- What is the impact of chronic rhinosinusitis with nasal polyps on quality of life, and what are the limitations of current therapies? (0:18)
- What biologics are currently available in this treatment setting? (2:43)
- What role are biologics likely to play in the future treatment of chronic rhinosinusitis with nasal polyps? (4:29)
Disclosures: Clinical trial funding and participation on advisory boards for: AstraZeneca, Genentech, GlaxoSmithKline, Sanofi Regeneron.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of AAAAI 2021 (Virtual).
